{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:03:07Z","timestamp":1785265387296,"version":"3.55.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA240139"],"award-info":[{"award-number":["P30CA240139"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Monoclonal gammopathy of undetermined significance (MGUS) is a precursor condition for multiple myeloma, and although environmental exposures have been implicated in its pathogenesis, it is unknown whether exposure to open-air burn pits used during U.S. military operations in Iraq affects prevalence of MGUS in active-duty service members (ADSMs). ADSMs represent a distinct young and physically fit population, with higher proportions of male and Black individuals compared to the general U.S. population. This retrospective cohort study evaluated MGUS prevalence among ADSMs. Participants included ADSMs deployed to Iraq with self-reported burn pit exposure (DEP-IQ;\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009534), ADSMs deployed to Germany without burn pit exposure (DEP-DEU;\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009534), and non-deployed ADSMs (NON-DEP;\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009521). Eligibility criteria included deployment \u2265180 days, age \u226535 years at deployment, and \u226510 years of continued military service. Serum samples collected 11\u201314 years post-deployment were analyzed using serum protein electrophoresis, immunofixation, and serum free light chain (sFLC) assays. MGUS and light-chain MGUS (LC-MGUS) prevalence were estimated using conventional and revised age-stratified sFLC reference intervals. MGUS + revised LC-MGUS prevalence did not differ between DEP-IQ (5.6%), DEP-DEU (4.3%), and NON-DEP (5.2%) cohorts. The overall total prevalence of MGUS + revised LC-MGUS was 5% and was higher in Black (10.4%) than White ADSMs (3.9%),\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001. When using conventional sFLC reference intervals, LC-MGUS was more frequently identified among deployed ADSMs (1.6%) compared with non-deployed ADSMs (0.2%); however, this association was no longer significant when revised reference intervals were applied. These findings suggest that military service may involve cumulative or non\u2013burn pit exposures contributing to plasma cell dysregulation. Application of updated sFLC reference ranges is critical to avoid overestimation of LC-MGUS. Long-term studies are warranted to define progression risk and inform targeted screening strategies in ADSMs.\n                  <\/jats:p>","DOI":"10.1038\/s41408-026-01511-0","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T10:25:07Z","timestamp":1778149507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["MGUS prevalence among active-duty military personnel"],"prefix":"10.1038","volume":"16","author":[{"given":"Dickran","family":"Kazandjian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-7760","authenticated-orcid":false,"given":"Christin","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Darmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Thoren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6485-4839","authenticated-orcid":false,"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"1511_CR1","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412\u20137. https:\/\/doi.org\/10.1182\/blood-2008-12-194241.","journal-title":"Blood"},{"key":"1511_CR2","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","volume":"113","author":"BM Weiss","year":"2009","unstructured":"Weiss BM, Abadie J, Verma P, Howard RS, Kuehl WM. A monoclonal gammopathy precedes multiple myeloma in most patients. Blood. 2009;113:5418\u201322. https:\/\/doi.org\/10.1182\/blood-2008-12-195008.","journal-title":"Blood"},{"key":"1511_CR3","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538\u201348. https:\/\/doi.org\/10.1016\/S1470-2045(14)70442-5.","journal-title":"Lancet Oncol"},{"key":"1511_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1182\/blood-2013-05-505487","volume":"123","author":"I Turesson","year":"2014","unstructured":"Turesson I, Kovalchik SA, Pfeiffer RM, Kristinsson SY, Goldin LR, Drayson MT, et al. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood. 2014;123:338\u201345. https:\/\/doi.org\/10.1182\/blood-2013-05-505487.","journal-title":"Blood"},{"key":"1511_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMoa01133202","volume":"346","author":"RA Kyle","year":"2002","unstructured":"Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564\u20139. https:\/\/doi.org\/10.1056\/NEJMoa01133202.","journal-title":"N Engl J Med"},{"key":"1511_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/blood-2010-01-262394","volume":"116","author":"O Landgren","year":"2010","unstructured":"Landgren O, Rajkumar SV, Pfeiffer RM, Kyle RA, Katzmann JA, Dispenzieri A, et al. Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood. 2010;116:1056\u20139. https:\/\/doi.org\/10.1182\/blood-2010-01-262394.","journal-title":"Blood"},{"key":"1511_CR7","doi-asserted-by":"publisher","first-page":"e340","DOI":"10.1016\/S2352-3026(22)00069-2","volume":"9","author":"H El-Khoury","year":"2022","unstructured":"El-Khoury H, Lee DJ, Alberge JB, Redd R, Cea-Curry CJ, Perry J, et al. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study. Lancet Haematol. 2022;9:e340\u2013e9. https:\/\/doi.org\/10.1016\/S2352-3026(22)00069-2.","journal-title":"Lancet Haematol"},{"key":"1511_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa1709974","volume":"378","author":"RA Kyle","year":"2018","unstructured":"Kyle RA, Larson DR, Therneau TM, Dispenzieri A, Kumar S, Cerhan JR, et al. Long-term follow-up of monoclonal gammopathy of undetermined significance. N Engl J Med. 2018;378:241\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1709974.","journal-title":"N Engl J Med"},{"key":"1511_CR9","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/leu.2014.34","volume":"28","author":"O Landgren","year":"2014","unstructured":"Landgren O, Graubard BI, Katzmann JA, Kyle RA, Ahmadizadeh I, Clark R, et al. Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia. 2014;28:1537\u201342. https:\/\/doi.org\/10.1038\/leu.2014.34.","journal-title":"Leukemia"},{"key":"1511_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00480-w","volume":"11","author":"S Rognvaldsson","year":"2021","unstructured":"Rognvaldsson S, Love TJ, Thorsteinsdottir S, Reed ER, Oskarsson J, Petursdottir I, et al. Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies. Blood Cancer J. 2021;11:94. https:\/\/doi.org\/10.1038\/s41408-021-00480-w.","journal-title":"Blood Cancer J"},{"key":"1511_CR11","doi-asserted-by":"publisher","first-page":"17003","DOI":"10.1289\/EHP6960","volume":"129","author":"JN Hofmann","year":"2021","unstructured":"Hofmann JN, Beane Freeman LE, Murata K, Andreotti G, Shearer JJ, Thoren K, et al. Lifetime pesticide use and monoclonal gammopathy of undetermined significance in a prospective cohort of male farmers. Environ Health Perspect. 2021;129:17003. https:\/\/doi.org\/10.1289\/EHP6960.","journal-title":"Environ Health Perspect"},{"key":"1511_CR12","doi-asserted-by":"publisher","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Hoppin JA, Beane Freeman LE, Cerhan JR, Katzmann JA, et al. Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study. Blood. 2009;113:6386\u201391. https:\/\/doi.org\/10.1182\/blood-2009-02-203471.","journal-title":"Blood"},{"key":"1511_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/jamaoncol.2018.0509","volume":"4","author":"O Landgren","year":"2018","unstructured":"Landgren O, Zeig-Owens R, Giricz O, Goldfarb D, Murata K, Thoren K, et al. Multiple Myeloma and its precursor disease among firefighters exposed to the World Trade Center disaster. JAMA Oncol. 2018;4:821\u20137.","journal-title":"JAMA Oncol"},{"key":"1511_CR14","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/milmed\/usae243","volume":"189","author":"DR Sayers","year":"2024","unstructured":"Sayers DR, DeStefano CB. Incident rate limitations in retrospective observational military cancer research. Mil Med. 2024;189:231\u20133. https:\/\/doi.org\/10.1093\/milmed\/usae243.","journal-title":"Mil Med"},{"key":"1511_CR15","doi-asserted-by":"publisher","first-page":"e254436","DOI":"10.1001\/jamanetworkopen.2025.4436","volume":"8","author":"I Robertson","year":"2025","unstructured":"Robertson I, Sgrignoli R, Dew A, Darmon S, Landgren O, Kazandjian D, et al. Long-term cancer risk of US service members exposed to burn pits in Iraq. JAMA Netw Open. 2025;8:e254436. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.4436.","journal-title":"JAMA Netw Open"},{"key":"1511_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1158\/1055-9965.EPI-22-0943","volume":"32","author":"N Sharifian","year":"2023","unstructured":"Sharifian N, Carey FR, Seay JS, Castaneda SF, Boyko EJ, Rull RP, et al. Risk and protective factors for cancer mortality among United States service members and veterans (2001-2018). Cancer Epidemiol Biomarkers Prev. 2023;32:606\u201316. https:\/\/doi.org\/10.1158\/1055-9965.EPI-22-0943.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1511_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13045-023-01521-6","volume":"17","author":"LW Liu","year":"2024","unstructured":"Liu LW, Wang M, Grandhi N, Schroeder MA, Thomas T, Vargo K, et al. The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans. J Hematol Oncol. 2024;17:3. https:\/\/doi.org\/10.1186\/s13045-023-01521-6.","journal-title":"J Hematol Oncol"},{"key":"1511_CR18","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/JOM.0000000000000775","volume":"58","author":"CT Mallon","year":"2016","unstructured":"Mallon CT, Rohrbeck MP, Haines MK, Jones DP, Utell M, Hopke PK, et al. Introduction to Department of Defense research on burn pits, biomarkers, and health outcomes related to deployment in Iraq and Afghanistan. J Occup Environ Med. 2016;58:S3\u2013S11. https:\/\/doi.org\/10.1097\/JOM.0000000000000775.","journal-title":"J Occup Environ Med"},{"key":"1511_CR19","first-page":"4","volume":"11","author":"R Chari","year":"2024","unstructured":"Chari R, Salazar HM, Skrabala L. Lessons from 9\/11 for supporting veterans exposed to military environmental hazards: veterans\u2019 issues in focus. Rand Health Q. 2024;11:4.","journal-title":"Rand Health Q"},{"key":"1511_CR20","unstructured":"National Academies of Sciences E, Medicine. Review of the Department of Veterans Affairs presumption decision process. In: Styka AN, Calonge BN, editors. Washington, DC: The National Academies Press; 2023. p. 160."},{"key":"1511_CR21","doi-asserted-by":"publisher","unstructured":"Ma H, Gupta P. Middle East deployment and lymphoid malignancies in US veterans: a matched case-control analysis. Cancers. 2025;17. https:\/\/doi.org\/10.3390\/cancers17193161.","DOI":"10.3390\/cancers17193161"},{"key":"1511_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.1285","author":"T Einarsson Long","year":"2025","unstructured":"Einarsson Long T, Rognvaldsson S, Thorsteinsdottir S, Sverrisdottir IS, Eythorsson E, Oskarsson JT, et al. New definition of light chain monoclonal gammopathy of undetermined significance. JAMA Oncol. 2025. https:\/\/doi.org\/10.1001\/jamaoncol.2025.1285.","journal-title":"JAMA Oncol"},{"key":"1511_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.97","volume":"7","author":"O Landgren","year":"2017","unstructured":"Landgren O, Graubard BI, Kumar S, Kyle RA, Katzmann JA, Murata K, et al. Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10-49 years old: a population-based study from the National Health and Nutrition Examination Survey. Blood Cancer J. 2017;7:e618. https:\/\/doi.org\/10.1038\/bcj.2017.97.","journal-title":"Blood Cancer J"},{"key":"1511_CR24","doi-asserted-by":"crossref","unstructured":"Sigurdur Y, Kristinsson SR, Thorsteinsdottir S, Reed ER, Oskarsson JTT, Petursdottir I, et al. Screening for monoclonal gammopathy of undetermined significance: a population-based randomized clinical trial. First results from the Iceland screens, treats, or prevents multiple myeloma (iStopMM) study. Blood. 2021;138:156.","DOI":"10.1182\/blood-2021-152333"},{"key":"1511_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.freeradbiomed.2025.09.035","volume":"241","author":"BJ Day","year":"2025","unstructured":"Day BJ, Huang J, Schaunaman N, Downey GP, Chu HW. Pro-inflammatory and oxidative responses to burn pit relevant desert particulate matter in macrophages: a role for TLR2 signaling. Free Radic Biol Med. 2025;241:330\u20137. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.09.035.","journal-title":"Free Radic Biol Med"},{"key":"1511_CR26","unstructured":"Bith-Melander P, Ratliff J, Poisson C, Jindal C, Ming Choi Y, Efird JT. Slow burns: a qualitative study of burn pit and toxic exposures among military veterans serving in Afghanistan, Iraq and throughout the Middle East. Ann Psychiatry Clin Neurosci. 2021;4:1042."},{"key":"1511_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood.2024027065","volume":"145","author":"IM Ghobrial","year":"2025","unstructured":"Ghobrial IM, Chabrun F. Is it time to screen for multiple myeloma?. Blood. 2025;145:253\u20135. https:\/\/doi.org\/10.1182\/blood.2024027065.","journal-title":"Blood"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01511-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01511-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:59:56Z","timestamp":1782784796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-026-01511-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1511"],"URL":"https:\/\/doi.org\/10.1038\/s41408-026-01511-0","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KT: Sebia (research support); the Binding Site\/ThermoFisher (research support). The other authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}